# Crown Bioscience

Crown Bioscience is an other based in Santa Clara, United States.

## Overview

- **Organization type:** other
- **Headquarters:** Santa Clara, United States
- **Region:** North America
- **Address:** Santa Clara, CA, United States
- **Assets under management:** Undisclosed
- **Website:** crownbio.com
- **LinkedIn:** https://www.linkedin.com/company/crown-bioscience-inc

## Regulatory record

- **Reports private funds:** No

## About

Advance translational oncology with Crown Bioscience, a full-service CRO delivering comprehensive preclinical and oncology CRO services worldwide.

## Sectors

- Healthcare Services

## Offices

- San Diego, CA, United States
- Frederick, MD, United States
- Kannapolis, NC, United States
- Osgathorpe, Loughborough, United Kingdom
- Leiden, Netherlands
- Hamburg, Germany
- Beijing, China
- Shanghai, China
- Suzhou, China
- Taicang, China
- Tokyo, Japan
- Suwon, South Korea
- Hyderabad, India
- Singapore

## Questions

### Which services does Crown Bioscience provide?

Crown Bioscience is a CRO offering translational oncology and immuno-oncology services, including preclinical models such as PDX, CDX, syngeneic models, GEMM, humanized mouse models, and organoid cultures. They also provide histopathology, genomics, and IC50 data services (per the firm's website).

### What types of preclinical models does Crown Bioscience offer?

The firm offers over 600 PDX organoid models, over 1000 cancer cell lines, over 200 CDX models, and over 100 syngeneic and GEMM models. Models include in vitro and in vivo preparations, with some derived from HUB organoid protocols (per the firm's website).

### Where are Crown Bioscience's facilities located?

Crown Bioscience has laboratory and office locations in San Diego, Frederick, and Kannapolis in the US; Loughborough in the UK; Leiden in the Netherlands; Hamburg in Germany; Beijing, Shanghai, Suzhou, and Taicang in China; Tokyo, Suwon, Hyderabad, and Singapore (per the firm's website).

### How does Crown Bioscience support regulatory changes in animal testing?

The company references the FDA Modernization Act 2.0 and notes the FDA's planned phase-out of animal testing requirements for certain therapies. It positions its human-relevant in vitro models as alternatives to animal studies (per the firm's website).

### Who are the primary decision-makers or owners at Crown Bioscience?

The available primary sources, including the firm's website, do not name any senior executives, board members, or owners. This information was not found in the consulted sources.

### Does Crown Bioscience have a known AUM or investment portfolio?

No. Crown Bioscience does not report AUM, investment assets, or capital deployment. It is a CRO providing services, not an investment firm. The AUM band display is 'Undisclosed.'

## Related profiles

- [Ping An Capital](https://altss.com/profile/ping-an-capital)
- [SugarCRM Inc.](https://altss.com/profile/sugarcrm-inc)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/crown-bioscience

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology